BMPR2 and pulmonary arterial hypertension: Finally, activating BMPRII/SMAD signaling by FK506 98 or enhancing BMP signaling by exogenous recombinant BMP9 54, 99 are interesting approaches that have shown promising results in PAH animal models, but could prove difficult to translate into treatments for patients (Table 1).